Detalles de la búsqueda
1.
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2.
Proc Natl Acad Sci U S A
; 119(39): e2117988119, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126099
2.
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model.
Eur Radiol
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329503
3.
Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief Review.
Int J Mol Sci
; 25(9)2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38731840
4.
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases.
Br J Cancer
; 129(8): 1274-1283, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37604930
5.
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial.
Breast Cancer Res Treat
; 197(3): 525-533, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525180
6.
Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.
BMC Cancer
; 23(1): 173, 2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810001
7.
Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study.
BMC Cancer
; 23(1): 615, 2023 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400804
8.
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
Proc Natl Acad Sci U S A
; 117(52): 33295-33304, 2020 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318171
9.
The anti-breast cancer potential of indole/isatin hybrids.
Arch Pharm (Weinheim)
; 356(11): e2300402, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650315
10.
Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
Breast Cancer Res Treat
; 196(1): 129-141, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076127
11.
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(3): 351-360, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581774
12.
Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component.
Br J Cancer
; 124(5): 975-981, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33335279
13.
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study.
Breast Cancer Res Treat
; 187(3): 759-768, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860389
14.
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.
J Transl Med
; 19(1): 75, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593381
15.
How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
Ann Surg Oncol
; 28(4): 2155-2168, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974696
16.
Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast Cancer.
Oncology
; 99(6): 359-364, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735903
17.
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients.
BMC Cancer
; 21(1): 807, 2021 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256710
18.
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer.
BMC Cancer
; 21(1): 707, 2021 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34130640
19.
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study.
J Med Internet Res
; 23(9): e27576, 2021 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34528890
20.
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
Cancer
; 126 Suppl 16: 3867-3882, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710660